Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,049 | -14,847 | -10,821 | -6,915 | -3,985 |
| Depreciation Amortization | 2 | 16 | 12 | 50 | 4 |
| Accounts payable and accrued liabilities | -465 | 218 | 362 | -105 | 1,359 |
| Other Working Capital | -1,109 | 1,568 | 2,360 | -222 | 911 |
| Other Operating Activity | 818 | -103 | -432 | -75 | -1,453 |
| Operating Cash Flow | $-3,802 | $-13,149 | $-8,520 | $-7,268 | $-3,164 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 29,827 | 29,827 | 12,041 | 12,041 |
| Financing Cash Flow | $N/A | $29,827 | $29,827 | $12,041 | $12,041 |
| Beginning Cash Position | 28,840 | 12,162 | 12,162 | 12,162 | 12,162 |
| End Cash Position | 25,037 | 28,840 | 33,469 | 16,935 | 21,038 |
| Net Cash Flow | $-3,802 | $16,678 | $21,307 | $4,773 | $8,876 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,802 | -13,149 | -8,520 | -7,268 | -3,164 |
| Free Cash Flow | -3,802 | -13,149 | -8,520 | -7,268 | -3,164 |